Related Experiment Video
Updated: Jun 24, 2026

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
Published on: May 5, 2023
Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria
Foluke A Fasola1, Taiwo R Kotila, Joshua O Akinyemi
1Department of Haematology, Medical Statistics and Environmental Health, College of Medicine, University of Ibadan, Ibadan, Nigeria. folukefasola@yahoo.com
Insights
Blood donor screening for hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV) showed fluctuating trends, particularly for HIV and HBV. Donor education and improved screening methods are recommended for a safer blood supply.
Area of Science:
- Virology
- Public Health
- Epidemiology
Background:
- Transfusion-transmitted viral infections pose a significant public health risk.
- Effective blood screening is crucial for preventing viral transmission.
- Limited data exists on viral marker trends in blood donor populations.
Purpose of the Study:
- To investigate the seroprevalence trends of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) among blood donors.
- To analyze changes in viral marker rates over a six-year period.
Main Methods:
- Retrospective analysis of blood bank records from a Nigerian tertiary hospital (2001-2006).
- Calculation of yearly seroprevalence rates for HBV, HCV, and HIV per 100 donations.
- Screening of 33,682 prospective donors.
Main Results:
- Overall seroprevalence: HBsAg (13.2%), HIV (7.66%), HCV (3.69%).
- HIV seroprevalence significantly fluctuated, peaking in 2003 and declining thereafter (p < 0.05).
- HBsAg seroprevalence also showed considerable fluctuation, while HCV remained consistent.
Conclusions:
- Significant fluctuations in HIV and HBsAg seroprevalence were observed.
- Potential variations in screening kit efficacy may contribute to observed fluctuations.
- Enhanced donor education and formal questionnaire-based donor selection are recommended to improve blood safety.
Objective:
Screening of blood before transfusion is an effective strategy to reduce transfusion-transmitted viruses. However, reports on viral marker trends among the donor population are scarce. This study looked at trends in the seroprevalence of hepatitis B (HBV) and C (HCV) and human immunodeficiency virus (HIV).
Method:
This is a retrospective study among blood donors at a tertiary hospital in Nigeria. We used the blood bank records to calculate yearly seroprevalence rates for HBV, HCV and HIV per 100 donations from 2001 to 2006.
Results:
A total of 33,682 prospective donors were screened, of which 13.2% were positive for HBsAg. The overall seroprevalence rates for HIV and HCV were 7.66% and 3.69%, respectively. HIV seroprevalence rose from 4.25% in 2001 to peak at 12.64% in 2003, before a steep drop to 6.35% in 2004 and a gradual decline to 5.70% in 2006 (p < 0.05).
Conclusion:
The seroprevalence rates for HIV and HBsAg fluctuated greatly during the study period while the seroprevalence of HCV was consistent. The screening kits used may be partly responsible for these fluctuations. Innovative programs for donor education, with the use of a formal questionnaire in donor selection, are recommended to ensure a safe donor population.
Related Concept Videos
Infectious Diseases and Their Occurrence
Viral Hepatitis I: Introduction
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Sexually Transmitted Infections
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Cytomegalovirus Disease